TRADstat
Phase 2 Recruiting
48 enrolled
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
Phase 2 Recruiting
250 enrolled
PRAVACUR-02
Phase 2 Recruiting
105 enrolled
RADICALPC
Phase NA Recruiting
6,000 enrolled
Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial
Phase 2 Withdrawn
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
Phase 2 Completed
115 enrolled 12 charts
Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children
Phase 1 Terminated
10 enrolled
Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence
Phase 2 Terminated
1 enrolled 5 charts
Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosis
Phase 3 Completed
323 enrolled
Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
Phase NA Completed
24 enrolled 11 charts
Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Phase 1/2 Terminated
6 enrolled 6 charts
PRODIGE 21
Phase 2 Completed
160 enrolled
Effect of GDC-0810 on the Pharmacokinetics of Pravastatin in Healthy Female Subjects of Non-Childbearing Potential
Phase 1 Completed
15 enrolled
Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer
Phase 3 Completed
846 enrolled
AGIM-1
Phase 4 Unknown
146 enrolled
Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia
Phase 1 Completed